Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets.
Read More…
Industry, Sector and Symbol
Industry Plastics materials & resins
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Phone980-299-5700
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.59 billion
Profitability
Miscellaneous
Employees5,900
Next Earnings Date5/13/2020 (Estimated)
OptionableOptionable
Albemarle (NYSE:ALB) Frequently Asked Questions
What is Albemarle's stock symbol?
Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."
How often does Albemarle pay dividends? What is the dividend yield for Albemarle?
Albemarle announced a quarterly dividend on Tuesday, October 29th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.368 per share on Thursday, January 2nd. This represents a $1.47 dividend on an annualized basis and a dividend yield of 1.72%. The ex-dividend date is Thursday, December 12th. This is an increase from Albemarle's previous quarterly dividend of $0.37. View Albemarle's Dividend History.
How were Albemarle's earnings last quarter?
Albemarle Co. (NYSE:ALB) released its quarterly earnings data on Wednesday, February, 19th. The specialty chemicals company reported $1.73 earnings per share for the quarter, missing analysts' consensus estimates of $1.75 by $0.02. The specialty chemicals company earned $992.60 million during the quarter, compared to analyst estimates of $1.01 billion. Albemarle had a return on equity of 16.12% and a net margin of 14.86%. The firm's revenue was up 7.7% compared to the same quarter last year. During the same quarter last year, the business earned $1.53 earnings per share. View Albemarle's Earnings History.
When is Albemarle's next earnings date?
What guidance has Albemarle issued on next quarter's earnings?
Albemarle issued an update on its FY20 earnings guidance on Wednesday, February, 19th. The company provided earnings per share guidance of $4.80-5.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.96. The company issued revenue guidance of $3.48-3.53, compared to the consensus revenue estimate of $3.53 billion.
What price target have analysts set for ALB?
25 brokerages have issued 12-month price targets for Albemarle's stock. Their forecasts range from $39.50 to $116.00. On average, they anticipate Albemarle's stock price to reach $86.41 in the next year. This suggests a possible upside of 0.7% from the stock's current price. View Analyst Price Targets for Albemarle.
What is the consensus analysts' recommendation for Albemarle?
25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 4 sell ratings, 11 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Albemarle.
Has Albemarle been receiving favorable news coverage?
Press coverage about ALB stock has trended very negative this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Albemarle earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned press coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Albemarle.
Who are some of Albemarle's key competitors?
Some companies that are related to Albemarle include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), NewMarket (NEU), Ashland Global (ASH), W. R. Grace & Co (GRA), Balchem (BCPC), Quaker Chemical (KWR), PolyOne (POL), HB Fuller (FUL), Sensient Technologies (SXT), Innospec (IOSP) and Stepan (SCL).
What other stocks do shareholders of Albemarle own?
Who are Albemarle's key executives?
Albemarle's management team includes the folowing people:
- Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 54)
- Mr. Scott A. Tozier, Exec. VP & CFO (Age 53)
- Mr. Donald J. LaBauve Jr., VP, Corp. Controller & Chief Accounting Officer (Age 52)
- Ms. Karen G. Narwold, Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 59)
- Mr. David Ryan, VP of Corp. Strategy & Investor Relations
Who are Albemarle's major shareholders?
Albemarle's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Franklin Resources Inc. (8.81%), State Street Corp (7.04%), Baillie Gifford & Co. (4.19%), Bank of New York Mellon Corp (2.32%), Geode Capital Management LLC (1.58%) and Bank of America Corp DE (1.49%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View Institutional Ownership Trends for Albemarle.
Which institutional investors are selling Albemarle stock?
ALB stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Bank of America Corp DE, AXA, CIBC Private Wealth Group LLC, Janus Henderson Group PLC, Franklin Resources Inc., Handelsbanken Fonder AB and Raymond James & Associates. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View Insider Buying and Selling for Albemarle.
Which institutional investors are buying Albemarle stock?
ALB stock was bought by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., State Street Corp, Bank of New York Mellon Corp, Amundi Pioneer Asset Management Inc., Baillie Gifford & Co., Westwood Holdings Group Inc., New York State Common Retirement Fund and DekaBank Deutsche Girozentrale. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow and Eric Norris. View Insider Buying and Selling for Albemarle.
How do I buy shares of Albemarle?
Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Albemarle's stock price today?
One share of ALB stock can currently be purchased for approximately $85.83.
How big of a company is Albemarle?
Albemarle has a market capitalization of $9.10 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 5,900 workers across the globe.View Additional Information About Albemarle.
What is Albemarle's official website?
How can I contact Albemarle?
Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]
MarketBeat Community Rating for Albemarle (NYSE ALB)
MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote "Outperform" if you believe ALB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALB will underperform the S&P 500 over the long term. You may vote once every thirty days.
